References
- Brew EL. Phenylpropanolamine and other over-the-counter vasoactive compounds. Hypertension 1988: 11(3 Pt 2): 7–10
- Messerli FH, Frohlich ED. High blood pressure: a side effect of drugs, poisons, and food. Arch Intern Med 1979: 139(6): 682–7
- The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988: 148(5): 1023–38
- Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs: a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 1987: 107(5): 628–35
- Webster J. Interactions of NSAIDs with diuretics and beta-blockers: mechanisms and clinical implications. Drugs 1985: 30(1): 32–41
- Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987: 147(5): 887–9
- Burnakis TG, Mioduch HJ. Combined therapy with captopril and potassium supplementation: a potential for hyperkalemia. Arch Intern Med 1984: 144(12): 2371–2
- Hodsman GP, Johnston CL. Angiotensin conlerling enzyme inhibitors: drug interactions. J Hypertens 1987: 5(1): 1–6
- Physicians' desk reference for nonprescription drugs. Oradell, NJ: Medical Economics, 1989
- Facts and comparisons. St Louis: JB Lippincott. 1989
- Radack K, Deck CC. Are oral decongestants safe in hypertension: an evaluation of the evidence and a framework for assessing clinical trials. Ann Allergy 1986: 56(5): 396–401
- Lasagna L. Phenylpropanolamine and blood pressure. (letter) JAMA 1985: 253(17): 2491–2
- Pentel P. Phenylpropanolamine and blood pressure. (letter) JAMA 1985: 253(17): 2492–3